In a meta-analysis, researchers analyzed the effects of probiotics on disease progression, depression, general health, and anthropometric measures in patients with relapsing remitting multiple sclerosis.
A team of researchers assessed the long-term safety and efficacy of dimethyl fumarate for the treatment of patients with relapsing remitting multiple sclerosis for up to 13 years.
Researchers shared their findings on the relationship between metabolic factors, like blood markers of lipid and carbohydrate metabolism, and the risk of developing amyotrophic lateral sclerosis.
This cross-sectional study assessed the frequency of peripapillary hyper-reflective ovoid masslike structures, a novel finding in retinal optical coherencetomography, in patients with early relapsing remitting MS and its link to disease duration in MS subtypes.
In a phase 3 trial presented at MDS 2021, researchers evaluated the efficacy and safety of DaxibotulinumtoxinA for Injection in the treatment of cervical dystonia in adults.
Using a series of case reports, the researchers assessed the various clinical phenotypes associated with variations in the VRK1 gene.
This meta-analysis of studies comparing 2 or more surgical approaches vs thymectomy aimed to identify the best option for myasthenia gravis patients.
Researchers evaluated the safety and efficacy of risdiplam in infants with type 1 spinal muscular atrophy compared with historical cohorts.
Researchers used sequencing data to evaluate the pathogenicity of TP73 variations in amyotrophic lateral sclerosis.
Early diagnosis and treatment of SMA can limit disease progression in children and adults, extending life expectancy and improving QOL.